51 RESULTS
CONFERENCE COVERAGE 2020-04-22 Conference Coverage Roche and Prothena today announced topline results from the first half of their Phase 2 trial of the α-synuclein antibody prasinezumab. Results were negative on the MDS-UPDRS, the primary outcome measure, but the company said it saw s
RESEARCH NEWS 2020-05-02 Research News Genome-wide association studies have uncovered a thicket of risk variants for neurologic diseases, but in which cells are these disease genes doing their dirty work? Merging GWAS with gene-expression signatures across the mouse nervous syste
RESEARCH NEWS 2020-05-22 Research News Part 1 of 2 As coronavirus lockdowns have led to noticeably clearer skies above many metropolitan areas, people are beginning to wonder anew about the effects of air pollution. Traffic and industrial exhaust have long been linked to respirat
RESEARCH NEWS 2020-05-23 Research News Part 2 of 2 For decades, studies of pulmonary and vascular systems dominated the air-pollution-research landscape. Researchers paid scant attention to the brain, which they considered safely ensconced behind the blood-brain barrier. But the
RESEARCH NEWS 2020-06-01 Research News Synapses are central in Alzheimer’s disease, but they are hard to study. The microscopic techniques that offer a glimpse at these tiny structures require expensive equipment and laborious ultra-sectioning of brain tissue, and cover only very
CONFERENCE COVERAGE 2020-04-15 Conference Coverage As the Alzheimer’s field branches out its therapeutics search beyond Aβ and tau, some of those approaches are showing glimmers of promise. The second biannual Advances in Alzheimer’s and Parkinson’s Therapies Focus Meeting (AAT-AD/PD),
